Literature DB >> 2181096

The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables.

C M Quinn1, N A Wright.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2181096     DOI： 10.1002/path.1711600202

Source DB:  PubMed          Journal:  J Pathol        ISSN： 0022-3417            Impact factor:   7.996


× No keyword cloud information.
  68 in total

1.  Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression.

Authors:  J Jankowski; R McMenemin; C Yu; D Hopwood; K G Wormsley
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

Review 2.  How malignant is malignant? A brief review of the microscopic assessment of human neoplasms, and the prediction of whether they will metastasize and kill.

Authors:  I Carr; N Pettigrew
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

3.  Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.

Authors:  Y M Shyr; C H Su; L H Wu; A F Li; J H Chiu; C W Wu; W Y Lui
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

4.  Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus.

Authors:  S Y Iftikhar; R J Steele; S Watson; P D James; K Dilks; J D Hardcastle
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

5.  Silver-stained nucleolar organizer regions in the normal, hyperplastic and neoplastic endometrium.

Authors:  K Niwa; Y Yokoyama; T Tanaka; H Mori; H Mori; T Tamaya
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model.

Authors:  Berwini B Endaya; Paula Y P Lam; Adrian C B Meedeniya; Jiri Neuzil
Journal:  Mol Oncol       Date:  2015-09-10       Impact factor: 6.603

7.  Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.

Authors:  H Kreipe; H H Wacker; H J Heidebrecht; K Haas; M Hauberg; M Tiemann; R Parwaresch
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

8.  Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.

Authors:  L Leoncini; M T Del Vecchio; T Megha; P Barbini; P Galieni; S Pileri; E Sabattini; F Gherlinzoni; P Tosi; R Kraft
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

9.  Proliferation indexes--a comparison between cutaneous basal and squamous cell carcinomas.

Authors:  M H al-Sader; E Doyle; E W Kay; M Bennett; C B Walsh; B Curran; C Milburn; M Leader
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

10.  AgNOR counts and determination of malignancy in stromal tumours of the stomach and small intestine.

Authors:  T W Beer; D C Rowlands; J Crocker
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.